Wedge Capital Management L L P NC Sells 2,730 Shares of McKesson Corporation $MCK

Wedge Capital Management L L P NC lessened its holdings in McKesson Corporation (NYSE:MCK) by 7.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 33,384 shares of the company’s stock after selling 2,730 shares during the quarter. Wedge Capital Management L L P NC’s holdings in McKesson were worth $27,385,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Brighton Jones LLC lifted its stake in McKesson by 46.3% during the fourth quarter. Brighton Jones LLC now owns 2,523 shares of the company’s stock worth $1,438,000 after purchasing an additional 798 shares during the period. Caxton Associates LLP bought a new stake in shares of McKesson in the 1st quarter valued at approximately $233,000. Sivia Capital Partners LLC grew its stake in shares of McKesson by 77.9% in the 2nd quarter. Sivia Capital Partners LLC now owns 685 shares of the company’s stock valued at $502,000 after purchasing an additional 300 shares during the period. American Century Companies Inc. raised its holdings in shares of McKesson by 16.0% in the 2nd quarter. American Century Companies Inc. now owns 13,718 shares of the company’s stock worth $10,052,000 after buying an additional 1,895 shares in the last quarter. Finally, J.W. Cole Advisors Inc. lifted its position in shares of McKesson by 6.7% during the 2nd quarter. J.W. Cole Advisors Inc. now owns 3,760 shares of the company’s stock worth $2,755,000 after buying an additional 236 shares during the period. Institutional investors and hedge funds own 85.07% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on MCK. TD Cowen lifted their price objective on McKesson from $1,000.00 to $1,012.00 and gave the company a “buy” rating in a report on Thursday, February 5th. Raymond James Financial set a $970.00 target price on shares of McKesson in a report on Thursday, March 5th. Evercore reissued an “outperform” rating on shares of McKesson in a report on Thursday, March 5th. Robert W. Baird set a $968.00 price target on shares of McKesson in a research report on Wednesday, January 14th. Finally, Mizuho upped their price objective on shares of McKesson from $880.00 to $885.00 and gave the stock a “neutral” rating in a research note on Thursday, February 5th. Thirteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $960.93.

Insiders Place Their Bets

In other McKesson news, EVP Thomas L. Rodgers sold 276 shares of the stock in a transaction on Monday, January 5th. The stock was sold at an average price of $816.18, for a total value of $225,265.68. Following the transaction, the executive vice president directly owned 2,268 shares in the company, valued at approximately $1,851,096.24. This trade represents a 10.85% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Maria Martinez sold 349 shares of McKesson stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $939.87, for a total value of $328,014.63. Following the completion of the sale, the director directly owned 301 shares of the company’s stock, valued at $282,900.87. This trade represents a 53.69% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 3,868 shares of company stock valued at $3,743,820 over the last quarter. Company insiders own 0.08% of the company’s stock.

McKesson Stock Performance

Shares of NYSE:MCK opened at $860.41 on Friday. The business has a fifty day moving average of $907.62 and a 200-day moving average of $838.81. McKesson Corporation has a twelve month low of $637.00 and a twelve month high of $999.00. The firm has a market cap of $105.39 billion, a PE ratio of 24.75, a price-to-earnings-growth ratio of 1.39 and a beta of 0.38.

McKesson (NYSE:MCK) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The business had revenue of $106.16 billion for the quarter, compared to the consensus estimate of $105.98 billion. During the same quarter in the prior year, the company earned $8.03 EPS. The firm’s quarterly revenue was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, analysts anticipate that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be paid a dividend of $0.82 per share. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. The ex-dividend date of this dividend is Monday, March 2nd. McKesson’s dividend payout ratio is 9.43%.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.